- 期刊
台灣藥價差亂象－醫療經濟學角度之分析及建議
Pharmaceutical market distortion under the current reimbursement policy-analyses and recommendations from a health economics’ perspective
參考文獻
Department of Health, Australian Government. The pharmaceutical benefit schedule: brand premium policy. Available at: http://www.pbs.gov.au/browse/brand-premium. Accessed February 1, 2016
財團法人中華民國消費者文教基金會：「藥」或不「要」：讓原廠藥與學名藥回歸市場機制，政府應嚴格稽查學名藥之藥性。http://www.consumers.org.tw/unit412.aspx?id=1973。引用2016/03/28。Consumers's Foundation, Chinese Taipei. Yes or No to generic medicines: reinforcement of quality control for generic drugs to facilitate the market competition between originator and generic brands.Available at: http://www.consumers.org.tw/unit412.aspx?id=1973. Accessed March 28, 2016. [In Chinese]
Yang, HL,Shen, LJ,Huang, CF(2012).Are brand-name drugs of better quaility than generics? Research at a medical center in Taiwan.J Food Drug Anal Analysis.20,6-11.
延伸閱讀
- Juway, L. (2020). 台灣製藥廠商核心能力價值評估:市場投資者之觀點 [master's thesis, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-2502202114225884
- 蔡宜芳（2011）。從消費者行為探討:如何在台灣推廣非處方藥之研究〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.03048
- 張維正（2010）。台灣地區中藥製劑出口定價之研究〔碩士論文，淡江大學〕。華藝線上圖書館。https://doi.org/10.6846/TKU.2010.01040
- 王興弘（2006）。The Developing Pattern of Pharmaceutical Industry -- The Cooperation and Competition between Multinational Pharmaceutical Group and Emerging Biotechnology Company〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2006.01961
- 陳恒毅（2014）。Evaluating the Key Factors of Retailer Product Development Management Based on the Viewpoint of Strategic Compensation: The Case of Medical Industry。危機管理學刊，11(1)，33-40。https://doi.org/10.6459/JCM.201403_11(1).0004